OCSL

Oaktree Specialty Lending Corporation NASDAQ Listed Jun 12, 2008

Financial Services ·Financial - Credit Services ·US · oaktreespecialtylending.com

$12.51

Mkt Cap $1.1B

52w Low $10.63 45.4% of range 52w High $14.77

50d MA $11.80 200d MA $12.89

P/E (TTM) 33.0x

EV/EBITDA 16.8x

P/B 0.8x

Debt/Equity 1.0x

ROE 2.2%

P/FCF 7.9x

RSI (14) —

ATR (14) —

Beta 0.56

50d MA $11.80

200d MA $12.89

Avg Volume 1.2M

About

Oaktree Specialty Lending Corporation is a business development company specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity and management buyouts in small and mid-sized companies. It seeks to invest in education serv…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 4, 2026	BMO	0.38	0.41	+7.9%	12.54	-0.6%	-3.3%	-3.3%	-3.2%	-1.3%	-1.8%	—
Nov 18, 2025	BMO	0.39	0.40	+3.6%	13.33	+0.5%	-0.1%	-0.1%	-1.1%	+1.1%	+2.1%	—
Aug 5, 2025	BMO	0.45	0.37	-17.8%	13.28	+0.0%	+0.6%	+0.6%	+0.1%	+0.9%	+1.4%	—
May 1, 2025	BMO	0.51	0.45	-11.8%	13.27	+1.2%	+2.4%	+2.4%	+1.1%	+1.2%	+0.5%	—
Feb 4, 2025	BMO	0.54	0.54	+0.0%	15.51	-0.1%	+1.7%	+1.7%	+0.3%	-0.2%	-0.3%	—
Nov 19, 2024	BMO	0.56	0.55	-1.8%	15.61	-1.0%	+0.4%	+0.4%	-0.3%	+1.5%	+2.6%	—
Aug 1, 2024	BMO	0.57	0.55	-3.5%	17.30	-1.2%	-4.6%	-4.6%	-9.1%	-6.8%	-7.4%	—
Apr 30, 2024	BMO	0.57	0.56	-1.8%	19.16	+0.0%	+1.8%	+1.8%	+0.7%	+0.7%	+0.2%	—
Feb 1, 2024	BMO	0.61	0.57	-6.6%	19.52	-0.6%	+1.0%	+1.0%	+0.0%	+0.7%	+0.4%	—
Nov 14, 2023	BMO	0.63	0.62	-1.6%	19.86	-0.1%	+0.4%	+0.4%	-0.1%	+0.3%	+0.1%	—
Aug 3, 2023	BMO	0.64	0.62	-3.1%	20.00	-0.1%	+0.6%	+0.6%	+1.4%	+1.4%	+0.1%	—
May 4, 2023	BMO	0.62	0.62	+0.0%	18.00	+0.9%	+0.2%	+0.2%	+2.4%	+1.9%	+3.3%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 13	JP Morgan	Maintains	Neutral → Neutral	—	$11.21	$11.21	+0.0%	-1.0%	-3.8%	-0.4%	+0.4%	+0.4%
Feb 5	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$12.54	$12.46	-0.6%	-3.3%	-3.2%	-1.3%	-1.8%	-1.5%
Apr 28	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$14.68	$14.71	+0.2%	+1.4%	-0.4%	-1.9%	-9.6%	-7.4%
Apr 24	JP Morgan	Maintains	Neutral → Neutral	—	$14.42	$14.40	-0.1%	+1.0%	+1.8%	+3.3%	+1.4%	-0.1%
Apr 8	Keefe, Bruyette & Woods	Maintains	Market Perform → Market Perform	—	$13.25	$13.61	+2.7%	-2.3%	+4.9%	+2.3%	+2.4%	+4.5%
Nov 22	Oppenheimer	Maintains	Perform → Perform	—	$15.56	$15.56	+0.0%	+1.9%	+3.0%	+2.8%	+4.6%	+5.0%
Nov 20	Keefe, Bruyette & Woods	Maintains	Market Perform → Market Perform	—	$15.61	$15.45	-1.0%	+0.4%	-0.3%	+1.5%	+2.6%	+2.5%
Nov 20	B. Riley Securities	Maintains	Neutral → Neutral	—	$15.61	$15.45	-1.0%	+0.4%	-0.3%	+1.5%	+2.6%	+2.5%
Nov 20	JP Morgan	Downgrade	Overweight → Neutral	—	$15.61	$15.45	-1.0%	+0.4%	-0.3%	+1.5%	+2.6%	+2.5%
Nov 19	JMP Securities	Downgrade	Market Outperform → Market Perform	—	$16.15	$16.00	-0.9%	-3.3%	-2.9%	-3.7%	-1.9%	-0.8%
Oct 29	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$16.45	$16.40	-0.3%	-1.5%	-0.4%	-1.4%	-3.0%	-5.2%
Aug 2	JP Morgan	Maintains	Overweight → Overweight	—	$17.30	$17.10	-1.2%	-4.6%	-9.1%	-6.8%	-7.4%	-6.4%
Aug 2	Wells Fargo	Maintains	Overweight → Overweight	—	$17.30	$17.10	-1.2%	-4.6%	-9.1%	-6.8%	-7.4%	-6.4%
Aug 2	B. Riley Securities	Maintains	Neutral → Neutral	—	$17.30	$17.10	-1.2%	-4.6%	-9.1%	-6.8%	-7.4%	-6.4%
Aug 2	Oppenheimer	Downgrade	Outperform → Perform	—	$17.30	$17.10	-1.2%	-4.6%	-9.1%	-6.8%	-7.4%	-6.4%
Jul 30	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$18.36	$18.36	+0.0%	-1.1%	-1.8%	-5.8%	-10.1%	-14.4%
Jul 29	JP Morgan	Maintains	Overweight → Overweight	—	$18.41	$18.46	+0.3%	-0.3%	-1.4%	-2.1%	-6.0%	-10.3%
Jul 26	Wells Fargo	Maintains	Overweight → Overweight	—	$18.11	$18.15	+0.2%	+1.7%	+1.4%	+0.2%	-0.4%	-4.5%
Apr 12	JP Morgan	Maintains	Overweight → Overweight	—	$19.48	$19.47	-0.1%	-1.1%	-1.3%	-1.0%	-0.3%	+0.0%
Mar 26	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$19.37	$19.37	+0.0%	+0.2%	+0.7%	+1.5%	-0.3%	+0.6%
Feb 2	Wells Fargo	Maintains	Overweight → Overweight	—	$19.52	$19.41	-0.6%	+1.0%	+0.0%	+0.7%	+0.4%	+0.8%
Feb 2	Keefe, Bruyette & Woods	Downgrade	Outperform → Market Perform	—	$19.52	$19.41	-0.6%	+1.0%	+0.0%	+0.7%	+0.4%	+0.8%
Jan 29	Wells Fargo	Maintains	Overweight → Overweight	—	$21.54	$21.54	+0.0%	-0.7%	-0.3%	-1.7%	-9.4%	-8.5%
Jan 8	B. Riley Securities	Downgrade	Buy → Neutral	—	$20.91	$20.78	-0.6%	+0.4%	+0.4%	+1.5%	+1.3%	+1.7%
May 5	Keefe, Bruyette & Woods	Maintains	Outperform → Outperform	—	$18.00	$18.17	+0.9%	+0.2%	+2.4%	+1.9%	+3.3%	+2.1%
Apr 18	Wells Fargo	Maintains	Overweight → Overweight	—	$18.96	$18.87	-0.5%	-1.6%	-0.7%	-1.5%	-1.1%	-0.7%
Mar 13	JMP Securities	Maintains	Market Outperform → Outperform	—	$18.52	$18.27	-1.3%	-0.6%	-1.3%	-1.6%	-1.7%	-3.6%
Feb 8	JP Morgan	Maintains	Overweight → Overweight	—	$20.51	$20.50	-0.0%	-2.8%	-4.5%	-2.9%	-1.9%	-1.6%
Nov 16	B. Riley Securities	Maintains	Buy → Buy	—	$20.88	$21.00	+0.6%	+2.0%	+2.0%	+2.6%	+2.7%	+3.4%
Nov 16	Wells Fargo	Maintains	Overweight → Overweight	—	$20.88	$21.00	+0.6%	+2.0%	+2.0%	+2.6%	+2.7%	+3.4%
Oct 24	Wells Fargo	Maintains	Overweight → Overweight	—	$18.72	$18.87	+0.8%	+2.2%	+5.9%	+5.1%	+5.1%	+6.6%
Oct 14	B. Riley Securities	Maintains	Buy → Buy	—	$18.66	$18.78	+0.6%	+0.3%	+1.9%	+2.1%	+1.0%	+0.5%
Nov 17	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$22.32	$22.38	+0.3%	+1.2%	+0.7%	-0.9%	-1.1%	-1.2%
Oct 25	Wells Fargo	Maintains	Overweight → Overweight	—	$22.41	$22.47	+0.3%	-0.7%	-1.2%	-1.5%	-0.7%	-1.3%
Aug 9	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$21.48	$21.60	+0.6%	+1.1%	+1.0%	+1.0%	+0.7%	+1.3%
Jun 24	Oppenheimer	Maintains	Outperform → Outperform	—	$20.19	$20.40	+1.0%	+0.9%	+0.3%	+0.3%	-0.6%	-0.6%
Aug 17	Deutsche Bank	Maintains	Buy → Buy	—	$15.09	$15.12	+0.2%	-0.2%	-0.6%	-1.2%	-1.0%	+0.0%
Jun 19	Janney Capital	Upgrade	Neutral → Buy	—	$13.26	$13.86	+4.5%	+4.1%	+2.0%	+2.0%	-0.3%	+1.1%
May 11	Deutsche Bank	Maintains	Buy → Buy	—	$12.81	$12.75	-0.5%	+0.0%	-3.7%	-6.8%	-6.3%	-4.9%
May 11	Wells Fargo	Maintains	Overweight → Overweight	—	$12.81	$12.75	-0.5%	+0.0%	-3.7%	-6.8%	-6.3%	-4.9%
May 8	Keefe, Bruyette & Woods	Maintains	Outperform → Outperform	—	$12.12	$12.27	+1.2%	+5.7%	+5.7%	+1.7%	-1.5%	-1.0%
Apr 27	Wells Fargo	Maintains	Overweight → Overweight	—	$11.49	$11.64	+1.3%	+5.2%	+3.1%	+5.0%	+4.7%	+5.5%
Mar 25	Wells Fargo	Maintains	Overweight → Overweight	—	$7.29	$7.65	+4.9%	+21.4%	+44.4%	+42.8%	+36.2%	+33.3%
Mar 6	National Securities	Maintains	Buy → Buy	—	$15.30	$15.21	-0.6%	-2.2%	-11.2%	-11.2%	-12.9%	-24.5%
Jan 15	Wells Fargo	Upgrade	Equal Weight → Overweight	—	$16.38	$16.71	+2.0%	+1.6%	+2.2%	+1.8%	+1.6%	+2.4%
Oct 10	Jefferies	Maintains	Buy → Buy	—	$15.27	$15.42	+1.0%	+2.0%	+1.8%	+1.0%	+1.8%	+1.2%
Jul 29	Janney Capital	Maintains	Neutral → Neutral	—	$15.84	$15.87	+0.2%	-0.2%	+1.3%	+0.9%	-0.6%	-0.2%
Dec 17	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$12.90	$12.96	+0.5%	-1.6%	-1.2%	-1.4%	-3.5%	-2.1%
Aug 21	Keefe Bruyette & Woods	Upgrade	Market Perform → Outperform	—	$14.94	$15.15	+1.4%	+0.2%	+1.2%	+1.4%	+1.4%	+1.8%
Aug 10	JP Morgan	Maintains	Overweight → Overweight	—	$14.94	$14.88	-0.4%	+0.0%	+0.4%	-0.2%	+0.4%	+0.4%

Recent Filings

8-K · 2.02 !! High

Oaktree Specialty Lending Corporation -- 8-K 2.02: Earnings Results

Oaktree Specialty Lending Corporation reported Q1 2026 earnings results, providing investors with updated financial performance metrics and operational updates for the quarter ending March 31, 2026.

May 5

8-K

BioXcel Therapeutics, Inc. -- 8-K Filing

BioXcel Therapeutics amended its registration rights agreement and warrant terms, updating governance provisions and investor protections in capital structure dealings.

Apr 17

8-K

Oaktree Specialty Lending Corporation -- 8-K Filing

Oaktree Specialty Lending Corporation's March 3, 2026 special meeting was adjourned without voting on a proposal to authorize issuing up to 25% additional shares below net asset value, lacking sufficient stockholder quorum.

Mar 4

8-K

Oaktree Specialty Lending Corporation -- 8-K Filing

Oaktree Specialty Lending Corporation's quarterly investment income declined to $75.1 million ($0.85 per share) in Q1 2026 from $77.3 million ($0.88 per share) in Q4 2025, signaling modest sequential earnings pressure.

Feb 4

Data updated apr 26, 2026 4:53pm · Source: massive.com